The US Food and Drug Administration will not be issuing a final OTC sunscreen drug monograph by 26 November, the deadline set by Congress in the Sunscreen Innovation Act of 2014.
The agency’s Theresa Michele, director of nonprescription drug products at the Center for Drug Evaluation and Research, confirmed the postponement during a 21 November meeting with the Personal Care Products
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?